Danaher Co. (DHR) Shares Sold by Connable Office Inc.

Connable Office Inc. lessened its stake in shares of Danaher Co. (NYSE:DHR) by 12.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 33,939 shares of the conglomerate’s stock after selling 4,735 shares during the period. Danaher makes up about 0.9% of Connable Office Inc.’s portfolio, making the stock its 19th biggest position. Connable Office Inc.’s holdings in Danaher were worth $4,481,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. CX Institutional boosted its holdings in shares of Danaher by 188.7% in the 1st quarter. CX Institutional now owns 205 shares of the conglomerate’s stock valued at $27,000 after acquiring an additional 134 shares during the last quarter. Laurel Wealth Advisors LLC purchased a new stake in shares of Danaher in the 4th quarter valued at $27,000. Lenox Wealth Management Inc. purchased a new stake in shares of Danaher in the 1st quarter valued at $40,000. Hanson McClain Inc. boosted its holdings in shares of Danaher by 852.9% in the 4th quarter. Hanson McClain Inc. now owns 324 shares of the conglomerate’s stock valued at $33,000 after acquiring an additional 290 shares during the last quarter. Finally, Executive Wealth Management LLC acquired a new position in shares of Danaher in the 4th quarter valued at $39,000. 79.98% of the stock is currently owned by institutional investors.

DHR opened at $132.04 on Friday. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32. Danaher Co. has a 1 year low of $94.59 and a 1 year high of $134.67. The firm has a market capitalization of $94.53 billion, a P/E ratio of 29.21, a PEG ratio of 2.52 and a beta of 1.02.



Danaher (NYSE:DHR) last posted its earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.06. The firm had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.80 billion. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The business’s revenue was up 3.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.99 EPS. As a group, equities research analysts forecast that Danaher Co. will post 4.77 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.51%. The ex-dividend date of this dividend is Thursday, June 27th. Danaher’s dividend payout ratio is presently 15.04%.

Several research firms recently issued reports on DHR. Zacks Investment Research upgraded shares of Danaher from a “sell” rating to a “hold” rating in a research note on Monday, May 6th. Needham & Company LLC reiterated a “buy” rating and issued a $141.00 target price (up from $138.00) on shares of Danaher in a research note on Wednesday, April 17th. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a $140.00 target price on shares of Danaher in a research note on Monday, March 4th. Janney Montgomery Scott boosted their target price on shares of Danaher from $136.00 to $174.00 and gave the company a “buy” rating in a research note on Wednesday, April 17th. Finally, Jefferies Financial Group boosted their target price on shares of Danaher to $140.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $131.75.

In other Danaher news, SVP Angela S. Lalor sold 3,091 shares of the company’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $132.23, for a total transaction of $408,722.93. Following the completion of the transaction, the senior vice president now directly owns 38,515 shares in the company, valued at $5,092,838.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Angela S. Lalor sold 4,534 shares of the company’s stock in a transaction on Wednesday, February 27th. The stock was sold at an average price of $127.25, for a total transaction of $576,951.50. Following the transaction, the senior vice president now owns 21,209 shares of the company’s stock, valued at $2,698,845.25. The disclosure for this sale can be found here. Insiders have sold 444,484 shares of company stock valued at $57,676,574 over the last 90 days. 11.40% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This piece was published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at https://dakotafinancialnews.com/2019/05/26/danaher-co-dhr-shares-sold-by-connable-office-inc.html.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Recommended Story: Convertible Shares

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.